State Street's crypto push, FDA delays review of Eli Lilly GLP-1
تحليل معلومات السوق
مدعوم بالذكاء الاصطناعيState Street is expanding its services into crypto and tokenized assets, while the FDA has delayed its review of several drugs from Eli Lilly, Sanofi, and Disc Medicine, impacting healthcare stocks.
Market impact analysis based on neutral sentiment with 70% confidence.
سياق المقال
Yahoo Finance Host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including State Street's (STT) push into crypto and tokenized assets products and healthcare stocks Eli Lilly (LLY), Sanofi (SNY), and Disc Medicine (IRON) after Reuters reports the US Food and Drug Administration (FDA) delayed its review for several drugs. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.
التحليل والرؤى المقدمة من AnalystMarkets AI.